NextPlat Corp. (NASDAQ:NXPL) Sees Large Growth in Short Interest

NextPlat Corp. (NASDAQ:NXPL) saw a large increase in short interest in January. As of January 15th, there was short interest totaling 196,412 shares, an increase of 34.2% from the December 31st total of 146,349 shares. Based on an average daily trading volume, of 84,362 shares, the short-interest ratio is currently 2.3 days. Approximately 1.3% of the company’s stock are sold short. Approximately 1.3% of the company’s stock are sold short. Based on an average daily trading volume, of 84,362 shares, the short-interest ratio is currently 2.3 days.

Institutional Investors Weigh In On NextPlat

A hedge fund recently bought a new stake in NextPlat stock. Simplicity Wealth LLC bought a new stake in shares of NextPlat Corp. (NASDAQ:NXPL) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 600,000 shares of the company’s stock, valued at approximately $497,000. Simplicity Wealth LLC owned about 2.31% of NextPlat at the end of the most recent quarter. 1.30% of the stock is owned by hedge funds and other institutional investors.

NextPlat Stock Up 0.3%

NASDAQ NXPL traded up $0.00 during mid-day trading on Tuesday, reaching $0.67. The stock had a trading volume of 34,521 shares, compared to its average volume of 55,200. The stock has a market cap of $17.55 million, a PE ratio of -2.22 and a beta of 1.23. NextPlat has a 1 year low of $0.43 and a 1 year high of $1.12. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.56 and a quick ratio of 2.80. The company has a fifty day moving average price of $0.64 and a 200 day moving average price of $0.72.

NextPlat (NASDAQ:NXPL) last posted its earnings results on Wednesday, November 12th. The company reported ($0.08) EPS for the quarter. NextPlat had a negative return on equity of 34.22% and a negative net margin of 14.58%.The business had revenue of $13.75 million during the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of NextPlat in a research note on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has an average rating of “Sell”.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.